破坏活动依赖的CELF2穿的遗传变异会导致神经元过度兴奋,学习缺陷和发作
medRxiv : the preprint server for health sciences
|July 16, 2025
概括
新的CELF2基因变异通过错误定位CELF2蛋白质,导致神经发育障碍. 这种错位导致神经元过度兴奋,发作和受影响个体的学习缺陷.
科学领域:
- 遗传学 是一个遗传学.
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 在CELF2基因中出现的新型异合体变异与罕见的神经发育障碍有关.
- 连接CELF2变异与特定临床表型的机制尚不清楚.
研究的目的:
- 研究CELF2相关神经发育障碍背后的机制.
- 确定CELF2变异,蛋白质局部化和临床表型之间的联系.
主要方法:
- 研究了14个具有de novo CELF2变异的个体队列.
- 利用诱导多能干细胞衍生的神经元和转基因小鼠模型.
- 研究了CELF2核细胞质的转移及其对神经元功能的影响.
主要成果:
- 导致细胞质错位的CELF2变体,而不是功能丧失,与有关.
- CELF2在刺激神经元中经历了活动依赖的穿;细胞质保留导致过度兴奋.
- CELF2调节涉及突触功能和神经元刺激性的mRNAs.
- AKT信号被确定为CELF2穿调节器和潜在的治疗标.
结论:
- CELF2错位化是CELF2相关的神经发育障碍的一个关键机制.
- 这些发现扩大了CELF2疾病的遗传和临床谱.
- 变种特定的机制将CELF2错位与和认知缺陷联系起来.
更多相关视频
08:22A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations
Published on: December 1, 2017
8.7K
07:43Immunohistochemical Visualization of Hippocampal Neuron Activity After Spatial Learning in a Mouse Model of Neurodevelopmental Disorders
Published on: May 12, 2015
11.4K
相关概念视频
Epilepsy and Seizures: Overview
285
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
285
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
455
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
455
